Bionomics Limited (ASX:BNO) Full Year Statutory Accounts (ASX:BNO) 18 Aug, 2011 09:47 AM Today Bionomics Limited (ASX:BNO) released Full Year Statutory Accounts Please download this document for detailed announcements.
Bionomics Limited (ASX:BNO) Bionomics` 2010/2011 Preliminary Final Results (ASX:BNO) 18 Aug, 2011 09:45 AM Today Bionomics Limited (ASX:BNO) released Bionomics 2010/2011 Preliminary Final Results - Directors' Report and Financial Statements -30 June 2011.
Bionomics Limited (ASX:BNO) BNC105 Clinical Trials Reach Key Milestones (ASX:BNO) 03 Aug, 2011 09:40 AM BNC105 CANCER CLINICAL TRIALS REACH KEY MILESTONES CLINICAL PROGRAM TO BE EXPANDED - Data from renal cancer trial supports progression of the trial: ...read more
Bionomics Limited (ASX:BNO) Lapse of Options (ASX:BNO) 29 Jun, 2011 04:35 PM Lapse of Options Bionomics Limited (ASX: BNO) advises that following the lapse of unlisted options issued pursuant to the Employee Share Option Plan (293,667 at $0.81), the number of unlisted opti...read more
Bionomics Limited (ASX:BNO) Phase I BNC105 Clinical Trial Published (ASX:BNO) 23 Jun, 2011 10:10 AM PHASE I BNC105 CLINICAL TRIAL PUBLISHED Publication in prestigious international cancer journal Trial identified dose for current Phase II trials and confirmed both safety profile an...read more
Bionomics Limited (ASX:BNO) Merck Serono Extends MS Collaboration with Bionomics (ASX:BNO) 09 Jun, 2011 09:40 AM MERCK SERONO EXTENDS MULTIPLE SCLEROSIS COLLABORATION WITH BIONOMICS - Research term extended, signalling progress in multiple sclerosis program - Collaboration uses Bion...read more
Bionomics Limited (ASX:BNO) BNC105 Renal Cancer Trial To Be Presented AT ASCO (ASX:BNO) 03 Jun, 2011 10:05 AM BNC105 RENAL CANCER TRIAL TO BE PRESENTED AT ASCO Bionomics Limited (ASX: BNO) (ADR: BMICY) will display a poster presentation outlining the BNC105 clinical trial in patients with progressiv...read more
Bionomics Limited (ASX: BNO) Open Briefing - Outlook and Strategic Focus (ASX:BNO) 25 May, 2011 11:30 AM Outlook and Strategic Focus after Institutional Placement Open Briefing with CEO & MD Deborah Rathjen Bionomics (ASX : BNO) is a drug discovery and development company focused on new ...read more
Bionomics Limited (ASX: BNO) Successful Register Repositioning Complete (ASX:BNO) 13 May, 2011 10:49 AM SUCCESSFUL REGISTER REPOSITIONING COMPLETE - Start-up Australia Ventures sells 60 million Bionomics shares at $0.57 to a wide range of domestic and international institutions. ...read more
Bionomics Limited (ASX:BNO) Start-up Australia Ventures Pty Ltd Sells 60 Million Shares In Bionomics (ASX:BNO) 12 May, 2011 11:22 AM Start-up Australia Ventures Pty Ltd Sells 60 Million Shares In Bionomics Please find attached a letter received from Start-up Australia Ventures Pty Ltd dated 12 May 2011.
Bionomics Limited (ASX:BNO) BNC210 - Further Validation (ASX:BNO) 10 May, 2011 05:25 PM INDEPENDENT STUDY PROVIDES FURTHER VALIDATION OF BNC210 FOLLOWING RECENT SUCCESS OF PHASE Ib TRIALS Study shows key link between the effectiveness of antidepressants and neurogenesis (the gr...read more
Bionomics Limited (ASX:BNO) Bionomics NOW May 2011 Newsletter (ASX:BNO) 06 May, 2011 05:25 PM Bionomics NOW May 2011 Newsletter Bionomics Limited (ASX:BNO) has released its Bionomics NOW May 2011 Newsletter.
Bionomics Limited (ASX:BNO) BNO Sells Thebarton Premises to Boost Cash Reserves (ASX:BNO) 04 May, 2011 10:58 AM Bionomics Sells Thebarton Premises to Substantially Boost Cash Reserves Bionomics Limited (ASX: BNO; ADR: BMICY) has entered into a contract to sell its head office and research facility in T...read more
Bionomics Limited (ASX:BNO) Bionomics April Investor Presentation (ASX:BNO) 14 Apr, 2011 08:50 AM Bionomics April Investor Presentation Bionomics Limited (ASX:BNO) has released its investor presentation given in April 2011 by Deborah Rathjen, CEO and Managing Director.
Bionomics Limited (ASX:BNO) Bionomics Presents at Needham Healthcare Conference (ASX:BNO) 06 Apr, 2011 10:05 AM Bionomics Presents at Needham Healthcare Conference Bionomics Limited (ASX: BNO) (ADR: BMICY) announced today that Dr. Deborah Rathjen, the company’s Chief Executive Officer and Managin...read more
